KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to $0.6.

  • Medtronic's Debt to Equity rose 243.6% to $0.6 in Q4 2025 from the same period last year, while for Oct 2025 it was $0.6, marking a year-over-year increase of 243.6%. This contributed to the annual value of $0.59 for FY2025, which is 1906.48% up from last year.
  • Medtronic's Debt to Equity amounted to $0.6 in Q4 2025, which was up 243.6% from $0.59 recorded in Q3 2025.
  • In the past 5 years, Medtronic's Debt to Equity ranged from a high of $0.6 in Q4 2025 and a low of $0.44 during Q3 2022
  • Its 5-year average for Debt to Equity is $0.52, with a median of $0.51 in 2022.
  • Per our database at Business Quant, Medtronic's Debt to Equity soared by 2094.66% in 2021 and then plummeted by 1985.23% in 2022.
  • Medtronic's Debt to Equity (Quarter) stood at $0.49 in 2021, then grew by 4.08% to $0.51 in 2022, then dropped by 5.03% to $0.49 in 2023, then grew by 19.74% to $0.58 in 2024, then increased by 2.44% to $0.6 in 2025.
  • Its last three reported values are $0.6 in Q4 2025, $0.59 for Q3 2025, and $0.59 during Q2 2025.